Anthracycline-Free and Anthracycline-Containing Neoadjuvant Carboplatin Chemotherapy in Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Phase II Trial of Anthracycline-Free and Anthracycline-Containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-Negative Breast Cancer (NeoSTOP)
Clin. Cancer Res 2020 Nov 18;[EPub Ahead of Print], P Sharma, BF Kimler, AP O'Dea, L Nye, YY Wang, R Yoder, JM Staley, L Prochaska, J Wagner, AL Amin, K Larson, C Balanoff, M Elia, G Crane, S Madhusudhana, M Hoffmann, M Sheehan, R Rodriguez, K Finke, RH Shah, D Satelli, A Shrestha, L Beck, R McKittrick, R Pluenneke, V Raja, V Beeki, L Corum, J Heldstab, S LaFaver, M Prager, M Phadnis, DP Mudaranthakam, RA Jensen, AK Godwin, R Salgado, K Mehta, QJ KhanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.